Systematic review of accuracy, benefits, and harms of multicancer detection tests for screening
Dr. Leila Kahwati
Screening for multiple types of cancer with a single blood test is potentially transformative. Systematic review of the literature through March 2025 found no controlled studies evaluating the benefit of blood-based multicancer detection (MCD) tests for screening in asymptomatic adults. Evidence was judged insufficient to evaluate harms and accuracy of use of MCD tests (video summary).
